Vitamin D receptor pathway is required for probiotic protection in colitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 309, Issue 5, 2015, Pages G341-G349

  Wu, Shaoping ^a   Yoon, Sonia ^b   Zhang, Yong Guo ^a   Lu, Rong ^a   Xia, Yinglin ^c   Wan, Jiandi ^d   Petrof, Elaine O ^e   Claud, Erika C ^f   Chen, Di ^a   Sun, Jun ^a  

^a RUSH UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d Rochester Institute of Technology   (United States)

^e QUEEN S UNIVERSITY   (Canada)

^f UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

AMP; Antimicrobial peptide; IBD; Inflammatory bowel disease; Lactobacillus plantarum; Lactobacillus rhamnosus strain GG; Probiotics; Salmonella; VDR; Vitamin D; Vitamin D receptor

Indexed keywords

ADENOSINE PHOSPHATE; CATHELICIDIN; COLECALCIFEROL; DEFENSIN ALPHA22; DEFENSIN ALPHA5; GAMMA INTERFERON; GENTAMICIN; INTERLEUKIN 12; INTERLEUKIN 4; PROBIOTIC AGENT; RIP 3 GAMMA PROTEIN; STREPTOMYCIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COLITIS; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LUCIFERASE ASSAY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANETH CELL; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA; SALMONELLOSIS; SIGNAL TRANSDUCTION; STOMACH PROTECTION; VITAMIN D DEFICIENCY; ANIMAL; C57BL MOUSE; COLITIS, ULCERATIVE; DRUG EFFECTS; GENETICS; HCT116 CELL LINE; METABOLISM; MICROBIOLOGY; MICROFLORA;

ANIMALS; COLITIS, ULCERATIVE; FEMALE; HCT116 CELLS; HUMANS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED C57BL; MICROBIOTA; PANETH CELLS; PROBIOTICS; RECEPTORS, CALCITRIOL; RNA, MESSENGER;

EID: 84940733267     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00105.2015     Document Type: Article

References (43)

1. Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53: 1129–1136, 2004.
2. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, Stone CD, Brunt EM, Xavier RJ, Sleckman BP, Li E, Mizushima N, Stappenbeck TS, Virgin HW. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456: 259–263, 2008.
3. Demay MB. Mechanism of vitamin D receptor action. Ann NY Acad Sci 1068: 204–213, 2006.
4. Fujimori S, Tatsuguchi A, Gudis K, Kishida T, Mitsui K, Ehara A, Kobayashi T, Sekita Y, Seo T, Sakamoto C. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease. J Gastroenterol Hepatol 22: 1199–1204, 2007.
5. Garcia Vilela E, DeLourdesDe Abreu Ferrari M, OswaldoDa Gama Torres H, Guerra Pinto A., Carolina Carneiro Aguirre A, Paiva Martins F, Marcos Andrade Goulart E, Sales Da Cunha A. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn’s disease in remission. Scand J Gastroenterol 43: 842–848, 2008.
6. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19: 1067–1077, 2005.
7. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998.
8. Jin D, Wu S, Zhang Yg Lu R, Xia Y, Dong H, Sun J. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther 996-1009, 2015.
9. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 88: 441-150.2010.
10. Kappelman MD, Rifas-Shiman SL, Porter CQ, Ollendorf DA, Sandler RS, Galanko JA, Finkelstein JA. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 135: 1907-1913, 2008.
11. Kato S. The function of vitamin D receptor in vitamin D action. J Biochem 127: 717-722, 2000.
12. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294: G208-G216, 2008.
13. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, McLachlan SM, Adams JS, Hewison M. Vitamin d deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151: 2423-2432, 2010.
14. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2: 308-315, 2005.
15. Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med 13: 117-124, 2007.
16. Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, Kong J, Musch M, Huang Y, Pekow J, Zheng C, Bissonnette M, Hanauer SB, Li YC. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest 123: 3983-3996, 2013.
17. Loftus EV Jr. The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol 5: 1383-1384, 2007.
18. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31: 1-20, 2002.
19. Miller SI, Mekalanos JJ. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bac- teriol 172: 2485-2490, 1990.
20. Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 12: 1162-1174, 2006.
21. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127: 1474-1487, 2004.
22. Rahimi R, Nikfar S, Rahimi F, Elahi B, Derakhshani S, Vafaie M, Abdollahi M. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci 53: 2524-2531, 2008.
23. Reiff C, Delday M, Rucklidge G, Reid M, Duncan G, Wohlgemuth S, Hormannsperger G, Loh G, Blaut M, Collie-Duguid E, Haller D, Kelly D. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 15: 1721-1736, 2009.
24. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390-407, 2006.
25. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastro- enterology 134: 577-594, 2008.
26. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231, 1998.
27. Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 76: 1077-1081, 2002.
28. Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, Tandon RK. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroen-terol Hepatol 7: 1202-1209, 1209.e1, 2009.
29. Sun J, Chang EB. Exploring gut microbes in human health and disease: pushing the envelope. Genes Dis 1: 132-139, 2014.
30. Sun J, Hobert ME, Duan Y, Rao AS, He TC, Chang EB, Madara JL. Crosstalk between NF-kB and fi-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 289: G129-G137, 2005.
31. Sun J, Hobert ME, Rao AS, Neish AS, Madara JL. Bacterial activation of ff-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol 287: G220-G227, 2004.
32. Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL, Li YC. Increased NF-kB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291: E315-E322, 2006.
33. Sun J, Mustafi R, Cerda S, Chumsangsri A, Xia YR, Li YC, Bisson-nette M. Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells. J Steroid Biochem Mol Biol 111: 37-40, 2008.
34. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 105: 20858-20863, 2008.
35. Wada K, Tanaka H, Maeda K, Inoue T, Noda E, Amano R, Kubo N, Muguruma K, Yamada N, Yashiro M, Sawada T, Nakata B, Ohira M, Hirakawa K. Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep 22: 1021-1025, 2009.
36. Walker A. Genome watch: probiotics stick it to the man. Nat Rev Microbiol 7: 843, 2009.
37. Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, Dionne S, Servant MJ, Bitton A, Seidman EG, Mader S, Behr MA, White JH. Direct and indirect induction by 1,25-dihydroxyvi-tamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 285: 2227-2231, 2010.
38. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912, 2004.
39. Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann NY Acad Sci 1173: 757-765, 2009.
40. Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, Sun J. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 177: 686-697, 2010.
41. Wu S, Xia Y, Liu X, Sun J. Vitamin D receptor deletion leads to reduced level of IkappaBalpha protein through protein translation, protein-protein interaction, and post-translational modification. Int J Biochem Cell Biol 42: 329-336, 2010.
42. Wu S, Zhang YG, Lu R, Xia Y, Zhou D, Petrof EO, Claud EC, Chen D, Chang EB, Carmeliet G, Sun J. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut 64: 1082-1094, 2015.
43. Ye Z, Petrof EO, Boone D, Claud EC, Sun J. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171: 882-892, 2007.